Related Experiment Video
Updated: Aug 25, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Alterations of Lipid Metabolism in the Heart in Spontaneously Hypertensive Rats Precedes Left Ventricular Hypertrophy
Tomasz K Bednarski1, Monika K Duda2, Pawel Dobrzyn1
1Laboratory of Molecular Medical Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland.
Insights
Cardiac lipid metabolism disturbances, specifically triglyceride accumulation due to reduced lipolysis and beta-oxidation, contribute to left ventricular hypertrophy and heart dysfunction in spontaneously hypertensive rats.
Area of Science:
- Cardiovascular Biology
- Metabolic Research
- Cardiac Pathophysiology
Background:
- Cardiac lipid metabolism disturbances are linked to cardiac hypertrophy and heart failure.
- Spontaneously hypertensive rats (SHRs) exhibit early diacylglycerol accumulation in cardiomyocytes.
- The precise role of lipid metabolism pathways in SHR cardiac dysfunction remains unclear.
Purpose of the Study:
- To investigate the impact of lipid synthesis and degradation pathway alterations on left ventricular (LV) hypertrophy development in SHRs.
- To analyze age-dependent changes in lipid metabolism in SHRs at 6 and 18 weeks.
Main Methods:
- Comparative analysis of Wistar Kyoto (WKY) and SHR rat models at 6 and 18 weeks of age.
- Quantification of triglyceride and free fatty acid levels in the left ventricle.
- Assessment of protein expression for key enzymes and regulators involved in fatty acid synthesis, TG synthesis, beta-oxidation, and lipolysis.
Main Results:
- SHRs displayed higher LV triglyceride and lower free fatty acid content compared to WKY rats.
- Reduced expression of de novo fatty acid synthesis proteins was observed in SHR cardiomyocytes.
- Lower adenosine monophosphate-activated protein kinase phosphorylation and peroxisome proliferator-activated receptor α in 18-week-old SHRs indicated decreased beta-oxidation.
- Decreased adipose triglyceride lipase (ATGL) activator and increased ATGL inhibitor suggested reduced lipolysis in SHR hearts.
Conclusions:
- Triglyceride accumulation in SHRs is associated with impaired lipolysis and beta-oxidation in cardiomyocytes.
- These metabolic alterations contribute to the development of left ventricular hypertrophy and myocardial dysfunction in SHRs.
Abstract:
Disturbances in cardiac lipid metabolism are associated with the development of cardiac hypertrophy and heart failure. Spontaneously hypertensive rats (SHRs), a genetic model of primary hypertension and pathological left ventricular (LV) hypertrophy, have high levels of diacylglycerols in cardiomyocytes early in development. However, the exact effect of lipids and pathways that are involved in their metabolism on the development of cardiac dysfunction in SHRs is unknown. Therefore, we used SHRs and Wistar Kyoto (WKY) rats at 6 and 18 weeks of age to analyze the impact of perturbations of processes that are involved in lipid synthesis and degradation in the development of LV hypertrophy in SHRs with age. Triglyceride levels were higher, whereas free fatty acid (FA) content was lower in the LV in SHRs compared with WKY rats. The expression of de novo FA synthesis proteins was lower in cardiomyocytes in SHRs compared with corresponding WKY controls. The higher expression of genes that are involved in TG synthesis in 6-week-old SHRs may explain the higher TG content in these rats. Adenosine monophosphate-activated protein kinase phosphorylation and peroxisome proliferator-activated receptor α protein content were lower in cardiomyocytes in 18-week-old SHRs, suggesting a lower rate of β-oxidation. The decreased protein content of α/β-hydrolase domain-containing 5, adipose triglyceride lipase (ATGL) activator, and increased content of G0/G1 switch protein 2, ATGL inhibitor, indicating a lower rate of lipolysis in the heart in SHRs. In conclusion, the present study showed that the development of LV hypertrophy and myocardial dysfunction in SHRs is associated with triglyceride accumulation, attributable to a lower rate of lipolysis and β-oxidation in cardiomyocytes.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Coronary Artery Disease I: Introduction

